Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

PHASE3

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped There is no longer equipoise. DSMB recommended termination.

Conditions

DRUG: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine)
DRUG: d4T/3TC/NVP (stavudine/lamivudine/nevirapine)
DRUG: AZT/3TC/ABC (zidovudine/lamivudine/abacavir)
DRUG: d4T/3TC/ABC (stavudine/lamivudine/abacavir)
DRUG: ddI/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir)
DRUG: ABC/ ddI or TDF / NVP or EFV (abacavir / didanosine or tenofovir / nevirapine or efavirenz)
DRUG: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)

University of Washington